Fragile X syndrome at the turn of the century

Molecular Medicine Today

Volumn 6, Issue 5, 2000, Pages 193-198

  Kooy, R Frank ^a   Willemsen, Rob ^b   Oostra, Ben A ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN FMRP; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

DIAGNOSTIC APPROACH ROUTE; FRAGILE X SYNDROME; GENE THERAPY; HUMAN; KNOCKOUT MOUSE; NONHUMAN; NUCLEOTIDE REPEAT; PATHOGENESIS; POINT MUTATION; PROTEIN DOMAIN; REVIEW; X CHROMOSOMAL INHERITANCE;

ANIMALS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MALE; MICE; MICE, KNOCKOUT; MINISATELLITE REPEATS; MUTATION; NERVE TISSUE PROTEINS; PROTEIN STRUCTURE, TERTIARY; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEATS;

EID: 0034193517     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(00)01674-9     Document Type: Review

References (45)

1. Kooy R.F.et al. The fragile X syndrome and other fragile site disorders. Results Probl. Cell Differ. 21:1998;1-46.
2. Imbert G.et al. FMR1 and mutations in fragile X syndrome: molecular biology, biochemistry, and genetics. Wells R.D., Warren S.T. Genetic Instabilities and Hereditary Neurological Diseases. 1998;27-53 Academic Press.
3. Hagerman R.J. Physical and behavioral phenotype. Hagerman R.J., Cronister A. Fragile X Syndrome: Diagnosis, Treatment, and Research. 1996;3-87 Johns Hopkins University Press.
4. Verkerk A.J.M.H.et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 65:1991;905-914.
5. Pieretti M.et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 66:1991;817-822.
6. Verheij C.et al. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature. 363:1993;722-724.
7. Devys D.et al. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat. Genet. 4:1993;335-340.
8. Khandjian E.W.et al. The fragile X mental retardation protein is associated with ribosomes. Nat. Genet. 12:1996;91-93.
9. Ashley C.T.et al. FMR-1 protein. conserved RNP family domains and selective RNA binding Science. 262:1993;563-566.
10. De Boulle K.et al. A point mutation in the FMR1 gene associated with fragile X mental retardation. Nat. Genet. 3:1993;31-35.
11. Sittler A.et al. Alternative splicing of exon 14 determines nuclear or cytoplasmatic localisation of fmr1 protein isoforms. Hum. Mol. Genet. 5:1996;95-102.
12. Eberhart D.E.et al. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet. 5:1996;1083-1091.
13. Siomi M.C.et al. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J. 14:1995;2401-2408.
14. Zhang Y.et al. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J. 14:1995;5358-5366.
15. Tamanini F.et al. Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P. Biochem. J. 343:1999;517-523.
16. Siomi M.C.et al. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol. Cell. Biol. 16:1996;3825-3832.
17. Tamanini F.et al. FMRP is associated to the ribosomes via RNA. Hum. Mol. Genet. 5:1996;809-813.
18. Willemsen R.et al. Association of FMRP with ribosomal precursor particles in the nucleolus. Biochem. Biophys. Res. Commun. 225:1996;27-33.
19. Feng Y.et al. Fragile X mental retardation protein. nucleocytoplasmic shuttling and association with somatodendritic ribosomes J. Neurosci. 17:1997;1539-1547.
20. Tamanini F.et al. Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations. Hum. Mol. Genet. 8:1999;863-869.
21. Feng Y.et al. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell. 1:1997;109-118.
22. Bakker C.E.et al. Fmr1 knockout mice. a model to study fragile X mental retardation Cell. 78:1994;23-33.
23. Kooy R.F.et al. Transgenic mouse model for the fragile X syndrome. Am. J. Med. Genet. 64:1996;241-245.
24. D'Hooge R.et al. Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience. 76:1997;367-376.
25. Godfraind J.-M.et al. Long-term potentiation in the hippocampus of fragile X knockout mice. Am. J. Med. Genet. 64:1996;246-251.
26. Comery T.A.et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. U. S. A. 94. 1997;5401-5404.
27. Hinton V.J.et al. Analysis of neocortex in three males with the fragile X syndrome. Am. J. Med. Genet. 41:1991;289-294.
28. Weiler I.J.et al. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5395-5400.
29. Musumeci S.A.et al. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia. 41:1999;19-23.
30. Rousseau F.et al. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. New Engl. J. Med. 325:1991;1674-1681.
31. Kooy R.F.et al. Molecular detection of dynamic mutations. Adolph K.W. Human Genome Methods. 1997;23-53 CRC Press.
32. Willemsen R.et al. Rapid antibody test for fragile X syndrome. Lancet. 345:1995;1147-1148.
33. Willemsen R.et al. Noninvasive test for fragile X syndrome, using hair root analysis. Am. J. Hum. Genet. 65:1999;98-103.
34. Wells R.D. Molecular basis of genetic instability of triplet repeats. J. Biol. Chem. 271:1996;2875-2878.
35. n triplet repeat array in Saccharomyces cerevisiae deficient in aspects of DNA metabolism. Mol. Cell. Biol. 19:1999;5675-5684.
36. Reyniers E.et al. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat. Genet. 4:1993;143-146.
37. Reyniers E.et al. Post-mortem examination of two fragile X brothers with an FMR1 full mutation. Am. J. Med. Genet. 84:1999;245-249.
38. Malter H.E.et al. Characterization of the full fragile X syndrome mutation in fetal gametes. Nat. Genet. 15:1997;165-169.
39. Bakker C.E.et al. Rescue of the fragile X knockout mouse. Neurosci. Res. Commun. 2000;. (in press).
40. Coffee B.et al. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 22:1999;98-101.
41. Eberhart D.E., Warren S.T. Nuclease sensitivity of permeabilized cells confirms altered chromatin formation at the fragile X locus. Somatic Cell Mol. Genet. 22:1996;435-441.
42. Chiurazzi P.et al. In vitro reactivation of the FMR1 gene involved in fragile X syndrome. Hum. Mol. Genet. 7:1998;109-113.
43. Chiurazzi P.et al. Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum. Mol. Genet. 8:1999;2317-2323.
44. Cameron E.E.et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21:1999;103-107.
45. Schwarze S.R.et al. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285:1999;1569-1572.